These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 15553042

  • 1. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N, Hoshino T, Irisawa H, Sakura T, Miyawaki S.
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [Abstract] [Full Text] [Related]

  • 2. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J, Lipton J.
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for Varicella-Zoster virus infection after allogeneic peripheral blood stem cell transplantation.
    Kim DH, Kumar D, Messner HA, Minden M, Gupta V, Kuruvilla J, Chae YS, Sohn SK, Lipton JH.
    Clin Transplant; 2008 Apr; 22(6):770-9. PubMed ID: 18707605
    [Abstract] [Full Text] [Related]

  • 4. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y, Mineishi S, Saito T, Saito A, Yamada S, Ohnishi M, Chizuka A, Niiya H, Suenaga K, Nakai K, Takeuchi T, Makimoto A, Tanosaki R, Kami M, Tanaka Y, Fujita S, Watanabe T, Kobayashi Y, Tobinai K, Takaue Y.
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [Abstract] [Full Text] [Related]

  • 5. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [Abstract] [Full Text] [Related]

  • 6. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation.
    Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S.
    Bone Marrow Transplant; 2005 Jun; 35(11):1065-9. PubMed ID: 15806119
    [Abstract] [Full Text] [Related]

  • 7. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
    Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
    [Abstract] [Full Text] [Related]

  • 8. One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
    Oshima K, Takahashi T, Mori T, Matsuyama T, Usuki K, Asano-Mori Y, Nakahara F, Okamoto S, Kurokawa M, Kanda Y.
    Transpl Infect Dis; 2010 Oct; 12(5):421-7. PubMed ID: 20626711
    [Abstract] [Full Text] [Related]

  • 9. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS, Miller W, Haake R, Weisdorf D.
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [Abstract] [Full Text] [Related]

  • 10. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
    Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, Khan AM, Feingold JM, Bona RD, Edwards RL, Dorsky D, Clive J, Mukherji B, Tutschka PJ.
    Bone Marrow Transplant; 1999 Mar; 23(5):469-74. PubMed ID: 10100561
    [Abstract] [Full Text] [Related]

  • 11. Varicella infection in adult renal allograft recipients: experience at one center.
    Rodriguez-Moreno A, Sanchez-Fructuoso AI, Calvo N, Ridao N, Conesa J, Marques M, Prats D, Barrientos A.
    Transplant Proc; 2006 Oct; 38(8):2416-8. PubMed ID: 17097954
    [Abstract] [Full Text] [Related]

  • 12. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [Abstract] [Full Text] [Related]

  • 13. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.
    Sempere A, Sanz GF, Senent L, de la Rubia J, Jarque I, López F, Arilla MJ, Guinot M, Martín G, Martínez J.
    Bone Marrow Transplant; 1992 Dec; 10(6):495-8. PubMed ID: 1362686
    [Abstract] [Full Text] [Related]

  • 14. Varicella-zoster virus infections after autologous bone marrow transplantation in children.
    Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J.
    Bone Marrow Transplant; 1989 Mar; 4(2):191-4. PubMed ID: 2650789
    [Abstract] [Full Text] [Related]

  • 15. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
    Tauro S, Toh V, Osman H, Mahendra P.
    Bone Marrow Transplant; 2000 Oct; 26(7):795-6. PubMed ID: 11042663
    [Abstract] [Full Text] [Related]

  • 16. [Varicella-zoster virus infection after hematopoietic stem cell transplantation].
    Akiyama H, Inoue T, Okoshi Y, Mori S, Ohashi K, Maeda Y, Sasaki T, Okuyama Y, Hiruma K, Sakamaki H.
    Rinsho Ketsueki; 2000 Jan; 41(1):20-4. PubMed ID: 10695394
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, Sato M, Machishima T, Terasako K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Kanda Y.
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [Abstract] [Full Text] [Related]

  • 18. Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation.
    Kalpoe JS, Kroes AC, Verkerk S, Claas EC, Barge RM, Beersma MF.
    Bone Marrow Transplant; 2006 Jul; 38(1):41-6. PubMed ID: 16715108
    [Abstract] [Full Text] [Related]

  • 19. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
    König C, Kleber M, Reinhardt H, Knop S, Wäsch R, Engelhardt M.
    Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
    [Abstract] [Full Text] [Related]

  • 20. [Acute abdomina pain as a presenting symptom of varicella-zoster virus infection in an allogeneic bone marrow transplant].
    Hamanishi T, Nishikawa H, Kobayashi M, Nakao T, Ohagi S, Sasaki H, Matsumoto G, Sanke T, Nanjo K.
    Rinsho Ketsueki; 1998 Jan; 39(1):53-8. PubMed ID: 9492554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.